An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
Clinical trial NCT06225856 · RECRUITING
Trial details
- NCT number
- NCT06225856
- Sponsor
- Shanghai Yuyao Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-26
- Primary completion
- 2026-12-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.